At the news
? NEUTRALIMPACT 2/10 SC 13G/A filed Nov 6, 2026 at 11:07 ET
T. Rowe Price Investment Management filed an amended Schedule 13G for Cabaletta Bio, reporting beneficial ownership of 28,138,417 shares (13.1% of common stock) as of October 31, 2026, up from 17,250,098 shares (8.0%) as of September 30, 2026. This is a routine passive stake increase by a large asset manager and has no material directional impact.
- T. Rowe Price Investment Management reported beneficial ownership of 28,138,417 shares of Cabaletta Bio common stock as of October 31, 2026.
- The stake represents 13.1% of the outstanding common stock.
- This is an amendment to a Schedule 13G, indicating passive investment intent.
- The filing was made pursuant to Rule 13d-1(b).
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access